Form D — EVIA Life Sciences Inc.
0002162667-26-000001 · filed Nov 2, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,498,154
- Reported amount sold
- $700,002
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- EVIA Life Sciences Inc.
- CIK
- 2162667
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- MIDTOWN TOWER 18F
TOKYO, M0 107-6218 - Phone
- 81 80 2105 3464
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Kosuke Takishima · Executive OfficerTokyo, M0 Find on LinkedIn ↗
-
Joshua Raphael Schwab · DirectorHenderson, NV Find on LinkedIn ↗
-
Michael Kim · DirectorHenderson, NV Find on LinkedIn ↗
-
Takahiro Ochiya · DirectorTokyo, M0 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗